The new facility will accelerate the biotech and pharmaceutical industry's development by manufacturing vaccines, cell and gene therapies, and protein-based therapies
The planned bioprocessing facility would support commercial manufacturing for biotech and pharmaceutical customers across Asia-Pacific.
Kyfora Bio will focus on the synthesis of cationic polymers, lipids, and other materials used in nucleic acid delivery for cell and gene therapies.
The new production line is equipped with the latest advanced manufacturing system to produce quality products of Alkaloids & APIs used in a wide range of pharmaceutical applications
The company plans to execute both these tenders at their API manufacturing unit located at Savli, Gujarat, India.
New Regional Processing Lab will serve Ahmedabad and the state of Gujarat
The new advanced regional processing lab will serve Nagpur city and the Vidarbha region
Upon closing, the Quakertown business will become an independent company called Microsize
The $44 million facility is part of Thermo Fisher's $650 million multi-year investment, announced last year, to help ensure flexible, scalable and reliable bioprocessing production capacity exists for critical materials used in developing new and existing biologics and vaccines, including for COVID-19
The company’s differentiated value proposition comes during a time of unprecedented disruption in the life science supply chain
Subscribe To Our Newsletter & Stay Updated
